No Data
After-Market Boost: Lantern Pharma (LTRN) Stock Jumps
Lantern Pharma Announces PCT Patent Application Publication for Innovative, High Performing, Machine Learning Model for Predicting Blood Brain Barrier Permeability of Drug-Candidates
Lantern Pharma Advances Cancer Therapies With RADR Platform and Global ADC Collaborations
Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer
Lantern Pharma Inc. (LTRN): AI-Driven Cancer Drug Development
Lantern Pharma Extends CSO's Employment Agreement
